13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognized and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. As a multifaceted disease, cancer requires multimodal care that integrates supportive interventions, specifically nutrition and exercise, to improve nutrient intake, muscle mass, physical functioning, quality of life, and treatment outcomes. An integrated team of healthcare providers that incorporates societies’ recommendations into clinical practice can help achieve the best possible outcomes. A multidisciplinary panel of experts in oncology, nutrition, exercise, and medicine participated in a 2-day virtual roundtable in October 2020 to discuss gaps and opportunities in oncology nutrition, alone and in combination with exercise, relative to current evidence and international societies’ recommendations. The panel recommended five principles to optimize clinical oncology practice: (1) position oncology nutrition at the center of multidisciplinary care; (2) partner with colleagues and administrators to integrate a nutrition care process into the multidisciplinary cancer care approach; (3) screen all patients for malnutrition risk at diagnosis and regularly throughout treatment; (4) combine exercise and nutrition interventions before (e.g., prehabilitation), during, and after treatment as oncology standard of care to optimize nutrition status and muscle mass; and (5) incorporate a patient-centered approach into multidisciplinary care.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s00520-021-06661-4.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: found
          • Article: not found

          Sarcopenia: European consensus on definition and diagnosis

          The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Definition and classification of cancer cachexia: an international consensus.

            To develop a framework for the definition and classification of cancer cachexia a panel of experts participated in a formal consensus process, including focus groups and two Delphi rounds. Cancer cachexia was defined as a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Its pathophysiology is characterised by a negative protein and energy balance driven by a variable combination of reduced food intake and abnormal metabolism. The agreed diagnostic criterion for cachexia was weight loss greater than 5%, or weight loss greater than 2% in individuals already showing depletion according to current bodyweight and height (body-mass index [BMI] <20 kg/m(2)) or skeletal muscle mass (sarcopenia). An agreement was made that the cachexia syndrome can develop progressively through various stages--precachexia to cachexia to refractory cachexia. Severity can be classified according to degree of depletion of energy stores and body protein (BMI) in combination with degree of ongoing weight loss. Assessment for classification and clinical management should include the following domains: anorexia or reduced food intake, catabolic drive, muscle mass and strength, functional and psychosocial impairment. Consensus exists on a framework for the definition and classification of cancer cachexia. After validation, this should aid clinical trial design, development of practice guidelines, and, eventually, routine clinical management. Copyright © 2011 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Exercise Guidelines for Cancer Survivors

              The number of cancer survivors worldwide is growing, with over 15.5 million cancer survivors in the United States alone-a figure expected to double in the coming decades. Cancer survivors face unique health challenges as a result of their cancer diagnosis and the impact of treatments on their physical and mental well-being. For example, cancer survivors often experience declines in physical functioning and quality of life while facing an increased risk of cancer recurrence and all-cause mortality compared with persons without cancer. The 2010 American College of Sports Medicine Roundtable was among the first reports to conclude that cancer survivors could safely engage in enough exercise training to improve physical fitness and restore physical functioning, enhance quality of life, and mitigate cancer-related fatigue.
                Bookmark

                Author and article information

                Contributors
                Martin.Chasen@williamoslerhs.ca
                Journal
                Support Care Cancer
                Support Care Cancer
                Supportive Care in Cancer
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0941-4355
                1433-7339
                23 November 2021
                23 November 2021
                2022
                : 30
                : 4
                : 3073-3083
                Affiliations
                [1 ]GRID grid.17089.37, ISNI 0000 0001 2190 316X, Human Nutrition Research Unit, Department of Agricultural, Food and Nutritional Science, , University of Alberta, ; Edmonton, AB Canada
                [2 ]GRID grid.7841.a, Department of Translation and Precision Medicine, , Sapienza University of Rome, ; Rome, Italy
                [3 ]GRID grid.63984.30, ISNI 0000 0000 9064 4811, Peri Operative Program, , McGill University Health Center, ; Montreal, QC Canada
                [4 ]GRID grid.26009.3d, ISNI 0000 0004 1936 7961, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, , Duke University School of Medicine, ; Durham, NC USA
                [5 ]GRID grid.428633.8, ISNI 0000 0004 0504 5021, Florida Cancer Specialists and Research Institute, ; Fort Myers, FL USA
                [6 ]GRID grid.14442.37, ISNI 0000 0001 2342 7339, Department of Medical Oncology, , Hacettepe University Cancer Institute, ; Sihhiye, Ankara, Turkey
                [7 ]Humana Healthcare Research, Portland, OR USA
                [8 ]GRID grid.420096.9, ISNI 0000 0004 0442 8266, Thompson Cancer Survival Center, ; Knoxville, TN USA
                [9 ]University of Texas Health/East Texas Cancer Institute, Athens, TX USA
                [10 ]GRID grid.417574.4, ISNI 0000 0004 0366 7505, Scientific & Medical Affairs, , Abbott Nutrition, ; Columbus, OH USA
                [11 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Department of Medicine, , University of Toronto, ; Toronto, Canada
                [12 ]GRID grid.498791.a, ISNI 0000 0004 0480 4399, William Osler Health System, ; Brampton, ON Canada
                [13 ]GRID grid.25073.33, ISNI 0000 0004 1936 8227, Department of Family Medicine, , McMaster University, ; Hamilton, ON Canada
                Author information
                http://orcid.org/0000-0002-3609-5641
                http://orcid.org/0000-0002-9809-3553
                http://orcid.org/0000-0002-0615-5922
                http://orcid.org/0000-0001-7850-6798
                http://orcid.org/0000-0003-4173-9103
                http://orcid.org/0000-0002-2297-7133
                http://orcid.org/0000-0001-5564-0222
                http://orcid.org/0000-0002-0406-9692
                Article
                6661
                10.1007/s00520-021-06661-4
                8857008
                34811570
                4b0e98c6-77f9-4410-8435-92c568f87124
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 1 July 2021
                : 27 October 2021
                Categories
                Review Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2022

                Oncology & Radiotherapy
                malnutrition,low muscle mass,nutrition,exercise,multimodal,multidisciplinary
                Oncology & Radiotherapy
                malnutrition, low muscle mass, nutrition, exercise, multimodal, multidisciplinary

                Comments

                Comment on this article